ANGELA MIDDLETON: Open Payments
NPI 1124382593 · ROLLA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,865 in 91 payments from 26 companies in 2025. Trend: 2023 $1,105 · 2024 $221 · 2025 $1,865
Food & beverage: $1,766Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $186 |
| Novartis Pharmaceuticals Corporation | 6 | $166 |
| JAZZ PHARMACEUTICALS INC. | 4 | $153 |
| UCB, Inc. | 11 | $151 |
| PFIZER INC. | 11 | $151 |
| SK Life Science, Inc. | 5 | $125 |
| ARGENX US, INC. | 6 | $117 |
| Amgen Inc. | 5 | $93 |
| Lundbeck LLC | 4 | $75 |
| TG Therapeutics, Inc. | 3 | $72 |
Products named: KESIMPTA, XYWAV, NURTEC ODT, VYVGART HYTRULO, UPLIZNA, REXULTI, QULIPTA, BRIUMVI.
Industry payments across MO — which companies pay providers there.
